BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38863630)

  • 41. Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience.
    Wang Y; Yu M; Yang JX; Cao DY; Yuan Z; Zhou HM; Zhang Y; Li L; Shen K; Wu H
    Int J Clin Oncol; 2019 Jun; 24(6):712-720. PubMed ID: 30746595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.
    Herrera Cappelletti E; Humann J; Torrejón R; Gambadauro P
    Hum Reprod Update; 2022 Feb; 28(2):282-295. PubMed ID: 34935045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Atypical polypoid adenomyoma: retrospective study about 8 cases from Jeanne-de-Flandre Hospital between 1996 and 2008].
    Clouqueur E; Lucot JP; Collinet P; Farine MO; Kerdraon O; Poncelet E
    Gynecol Obstet Fertil; 2014 Feb; 42(2):84-91. PubMed ID: 22306097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case of atypical polypoid adenomyoma that possibly underwent a serial progression from endometrial hyperplasia to carcinoma.
    Fukuda M; Sakurai N; Yamamoto Y; Taoka H; Asakawa Y; Kurasaki A; Oharaseki T; Takahashi K; Kubushiro K
    J Obstet Gynaecol Res; 2011 May; 37(5):468-71. PubMed ID: 21272150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
    Gong Q; Chen X; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hysteroscopic treatment of atypical polypoid adenomyoma diagnosed incidentally in a young infertile woman.
    Di Spiezio Sardo A; Mazzon I; Gargano V; Di Carlo C; Guida M; Mignogna C; Bifulco G; Nappi C
    Fertil Steril; 2008 Feb; 89(2):456.e9-12. PubMed ID: 17706212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hysteroscopic treatment assisted by photodynamic diagnosis for atypical polypoid adenomyoma: A report of two cases.
    Matoba Y; Banno K; Kobayashi Y; Yamagami W; Nakamura M; Kisu I; Aoki D
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102583. PubMed ID: 34673272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy.
    Chen J; Cao D; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Shen K
    Front Oncol; 2021; 11():738370. PubMed ID: 34568074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
    Peng H; Jiang J; Li X
    Reprod Sci; 2022 Nov; 29(11):3278-3284. PubMed ID: 35641856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment.
    Peng H; Jiang J; Li L; Hao Z; Lian H; Du H; Wang W
    Gynecol Oncol; 2024 Apr; 186():154-160. PubMed ID: 38691985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment of a rare case of atypical polypoid adenomyoma of the uterus in a menopausal patient: a case report.
    Thanasa EI; Thanasa AI; Paraoulakis IE; Kamaretsos EK; Grapsidi VA; Kontogeorgis GP; Gerokostas EA; Chasiotis AN; Kontochristos VC; Thanasas IK
    Pan Afr Med J; 2023; 44():118. PubMed ID: 37275297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study.
    Wang Y; Zhou R; Zhang X; Liu H; Shen D; Wang J
    BMC Womens Health; 2021 Jun; 21(1):252. PubMed ID: 34162378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
    Yang HC; Liu JC; Liu FS
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):90-93. PubMed ID: 30638488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analyze of obesity indicators and effect of fertility preservation treatment in patients with endometrial atypical hyperplasia and early endometrial cancer].
    Bo LL; Wang YQ; Liu YY; Li XD; Zhou R; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):767-774. PubMed ID: 36299180
    [No Abstract]   [Full Text] [Related]  

  • 57. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
    Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
    Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical polypoid adenomyoma and hysteroscopic endometrial ablation.
    Vilos GA; Ettler HC
    J Obstet Gynaecol Can; 2003 Sep; 25(9):760-2. PubMed ID: 12970811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
    Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
    Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
    Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.